Armstrong DG, Lavery LA, Boulton AJ. Negative pressure wound therapy via vacuum-assisted closure following partial foot amputation: what is the role of wound chronicity? Int Wound J. 2007;4(1):79-86.
Armstrong DG, Lavery LA; Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005;366(9498):1704-1710.
Armstrong DG, Marston WA, Reyzelman AM, et al. Comparison of negative pressure wound therapy with an ultraportable mechanically powered device vs. traditional electrically powered device for the treatment of chronic lower extremity ulcers: a multicenter randomized-controlled trial. Wound Repair Regen. 2011;19(2):173-180.
Armstrong DG, Marston WA, Reyzelman AM, et al. Comparative effectiveness of mechanically and electrically powered negative pressure wound therapy devices: a multicenter randomized controlled trial. Wound Repair Regen. 2012;20(3):332-341.
Association for the Advancement of Wound Care (AAWC). Guideline of pressure ulcer guidelines. [AAWC Web site]. 2010. Available at: https://aawconline.memberclicks.net/resources. Accessed July 21, 2023.Association for the Advancement of Wound Care (AAWC). International consolidated venous ulcer guideline (ICVUG) [AAWC Web site]. 2015. Available at:https://aawconline.memberclicks.net/resources. Accessed July 21, 2023.Bloemen MC, van der Wal MB, Verhaegen PD, et al. Clinical effectiveness of dermal substitution in burns by topical negative pressure: a multicenter randomized controlled trial. Wound Repair Regen. 2012; 20(6):797-805.Braakenburg A, Obdeijn MC, Feitz R, et al. The clinical efficacy and cost effectiveness of the vacuum-assisted closure technique in the management of acute and chronic wounds: a randomized control trial. Plast Reconstr Surg. 2006;118(2):390-397.Centers for Medicare & Medicaid Services (CMS). Medicare Learning Network (MLN) Matters. SE17027: Clarification of billing and payment policies for negative pressure wound therapy (NPWT) using a disposable device. [CMS Web site]. Original: 01/01/2017. (Revised 06/11/2019). Available at: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/SE17027.pdf. Accessed July 21, 2023.Centers for Medicare & Medicaid Services (CMS). Federal Register. Medicare Program; End-stage renal disease prospective payment system, payment for renal dialysis services furnished to individuals with acute kidney injury, end-stage renal disease quality incentive program, durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) fee schedule amounts, DMEPOS competitive bidding program (CBP) amendments, standard elements for a DMEPOS order, and master list of DMEPOS items potentially subject to a face-to-face encounter and written order prior to delivery and/or prior authorization requirements for calendar year (CY) 2020; Final Rule. [Federal Register Web site]. 01/01/2020. Available at: https://www.federalregister.gov/documents/2019/11/08/2019-24063/medicare-program-end-stage-renal-disease-prospective-payment-system-payment-for-renal-dialysis. Accessed July 21, 2023.
Cooper HJ, Singh DP, Gabriel A, et al. Closed incision negative pressure wound therapy versus standard of care in reduction of surgical site complications: A systematic review and meta-analysis. Plast Reconstr Surg Glob Open. 2023;11(3):e4722.
Dumville JC, Hinchliffe RJ, Cullum N, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev. 2013;10:CD010318.
Dumville JC, Munson C. Negative pressure wound therapy for partial-thickness burns. Cochrane Database Syst Rev. 2012;12:CD006215.
Dumville JC, Land L, Evans D, Peinemann F. Negative pressure wound therapy for treating leg ulcers. Cochrane Database Syst Rev. 2015;7:CD011354.
Fong KD, Hu D, Eichstadt SL, et al. Initial clinical experience using a novel ultraportable negative pressure wound therapy device. Wounds. 2010;22(9):230-236.
Fong KD, Hu D, Eichstadt S, et al. The SNaP system: biomechanical and animal model testing of a novel ultraportable negative-pressure wound therapy system. Plast Reconstr Surg. 2010;125(5):1362-1371.
Gombert A, Babilon M, Barbati ME, et al. Closed incision negative pressure therapy reduces surgical site infections in vascular surgery: a prospective randomized trial (AIMS Trial). Eur J Vasc Endovasc Surg. 2018;56(3):442-448.
Grauhan O, Navasardyan A, Hofmann M, et al. Prevention of poststernotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013;145(5):1387-1392.
Hussamy DJ, Wortman AC, McIntire DD, et al. Closed incision negative pressure therapy in morbidly obese women undergoing cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2019;134(4):781-789.
Hutton D, Sheehan P. Comparative effectiveness of the SNaPTM wound care system. International Wound Journal. 2011;8(2):196-205.
Hyldig N, Vinter CA, Mogensen O, et al. Prophylactic incisional negative pressure wound therapy reduces the risk of surgical site infection after caesarean section in obese women: a pragmatic randomised clinical trial. BJOG. 2019;126:628-635.
Iheozor-Ejiofor Z, Newton K, Dumville JC, et al. Negative pressure wound therapy for open traumatic wounds. Cochrane Database Syst Rev. 2018;7:CD012522.
Karlakki SL, Hamad AK, Whittall C, et al. Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: a randomized controlled trial. Bone Joint Res. 2016;5(8):328-337.
Landsman A. Analysis of the SNaP Wound Care System, a negative pressure wound device for treatment of diabetic lower extremity wounds. J Diabetes Sci Technol. 2010;4(4):831-832.
Lerman B, Oldenbrook L, Eichstadt SL, et al. Evaluation of chronic wound treatment with the SNaP wound care system vs. modern dressing protocols. Plast Reconstr Surg. 2010;126:1153-1161.
Lerman B, Oldenbrook L, Ryu J, et al. The SNaP Wound Care System: a case series using a novel ultraportable negative pressure wound therapy device for the treatment of diabetic lower extremity wounds. J Diabetes Sci Technol. 2010;4(4):825-830.
Li HZ, Xu XH, Wang DW, et al. Negative pressure wound therapy for surgical site infections: a systematic review and meta-analysis of randomized controlled trials. Clin Microbiol Infect. 2019;25(11):1328-1238.
Liu Z, Dumville JC, Hinchliffe RJ, et al. Negative pressure wound therapy for treating foot wounds in the people with diabetes mellitus. Cochrane Database Syst Rev. 2018;10:CD010318.
Marston WA, Armstrong DG, Reyzelman AM, et al. A multicenter randomized controlled trial comparing treatment of venous leg ulcers using mechanically versus electrically powered negative pressure wound therapy. Adv Wound Care (New Rochelle). 2015;4(2):75-82.
Murphy PB, Knowles S, Chadi SA, et al. Negative pressure wound therapy use to decrease surgical nosocomial events in colorectal resections (NEPTUNE): A randomized controlled trial. Ann Surg. 2019;270(1):38-42.
National Institute for Health and Care Excellence (NICE). Cesarean birth [NG192]. 2021. https://www.nice.org.uk/guidance/ng192. Accessed July 21, 2023.
National Institute for Health and Care Excellence (NICE). Diabetic Foot Problems: Prevention and Management [NG19]. 2019. https://www.nice.org.uk/guidance/ng19. Accessed July 21, 2023.
National Institute for Health and Care Excellence (NICE). Negative pressure wound therapy for the open abdomen [IPG467]. [NICE Web site]. 2013. Available at: https://www.nice.org.uk/guidance/ipg467. Accessed July 21, 2023.
National Institute for Health and Care Excellence (NICE). Pressure ulcers: prevention and management [CG179]. [NICE Web Site]. 2014. Available at: https://www.nice.org.uk/guidance/cg179. Accessed July 21, 2023.
Noridian. Local Coverage Determination (LCD). Negative pressure wound therapy pumps (L33821): [Noridian Web site]. Original: 10/01/2015. (Revised: 05/01/2021). Available at: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33821. Accessed July 21, 2023.
Noridian. Local Coverage Article (LCA). Negative pressure wound therapy pumps (A52511): [Noridian Web site]. Original: 10/01/2015. (Revised: 08/15/2021). Available at: Article - Negative Pressure Wound Therapy Pumps - Policy Article (A52511) (cms.gov). Accessed July 21, 2023.
Norman G, Goh EL, Dumville JC, et al. Negative pressure wound therapy for surgical wounds healing by primary closure. Cochrane Database Syst Rev. 2020;6:CD009261.
O'Leary DP, Peirce C, Anglim B, et al. Prophylactic negative pressure dressing use in closed laparotomy wounds following abdominal operations: a randomized, controlled, open-label trial: The P.I.C.O. Trial. Ann Surg. 2017;265(6):1082-1086.
Rhee SM, Valle MF, Wilson LM, et al. Negative pressure wound therapy technologies for chronic wound care in the home setting: a systemic review. Wound Rep Reg. 2015;23:506-517.
Samson D, Lefevre F, Aronson N. Wound-healing technologies: low-level laser and vacuum-assisted closure. Evid Rep Tech Assess (Summ). 2004;(111):1-6.
Saunders C, Nherera LM, Horner A, Trueman P. Single-use negative pressure wound therapy versus conventional dressings for closed surgical incisions: systematic literature review and meta-analysis. BJS Open. 2021;00:1-8.
Schwartz JA, Goss SG, Facchin F, et al. Single-use negative pressure wound therapy for the treatment of chronic lower leg wounds. J Wound Care. 2015;24(Suppl 2):S4-S9.
Seidel D, Diedrich S, Herrle F, et al. Negative pressure wound therapy vs conventional wound treatment in subcutaneous abdominal wound healing impairment. JAMA Surg. 2020;155(6):469-478.
Singh DP, Gabriel A, Parvizi J, et al. Meta-analysis of comparative trials evaluating a single-use closed-incision negative-pressure therapy system. Plast Reconstr Surg. 2019;143:41S-46S.
Strugala V, Martin R. Meta-analysis of comparative trials evaluating a prophylactic single-use negative pressure wound therapy system for the prevention of surgical site complications. Surg Infect (Larchmt). 2017;18(7):810-819.
Tuuli MG, Liu J, Tita ATN, et al. Effect of prophylactic negative pressure wound therapy vs standard wound dressing on surgical-site infection in obese women after cesarean delivery: A randomized clinical trial. JAMA. 2020;324(12):1180-1189.
US Food and Drug Administration (FDA). Center for Devices and Radiological Health. Prevena™ Incision Management System. 510(k) summary. [FDA Web site]. 11/06/2015. Available at:
https://www.accessdata.fda.gov/cdrh_docs/pdf15/K150006.pdf. Accessed July 21, 2023.
US Food and Drug Administration (FDA). Center for Devices and Radiological Health. Product classification. Negative pressure wound therapy powered suction pump. [FDA Web site] 03/10/2014. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm?ID=OMP. Accessed July 21, 2023.
US Food and Drug Administration 510(k) Premarket Notification Database. Medela® INVIA Wound Therapy. No K080357. Rockville, MD: FDA. July 24, 2008. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf8/K080357.pdf. Accessed July 21, 2023.
US Food and Drug Administration 510(k) Premarket Notification Database. NPD 1 000 Negative Pressure Wound Therapy System. No. K080275. Rockville, MD: FDA. October 09, 2008. Available at:
http://www.accessdata.fda.gov/cdrh_docs/pdf8/K080275.pdf. Accessed July 21, 2023.
US Food and Drug Administration 510(k) Premarket Notification Database. PICO Single Use Negative Pressure Wound Therapy System. No. K111170. Rockville, MD: FDA. December 15, 2011. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf11/K111170.pdf. Accessed July 21, 2023.
US Food and Drug Administration 510(k) Premarket Notification Database. PICO Single Use Negative Pressure Wound Therapy System. No. K112127. Rockville, MD: FDA. May 16, 2012. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf11/K112127.pdf. Accessed July 21, 2023.
US Food and Drug Administration 510(k) Premarket Notification Database. RENASYS GO Negative Pressure Wound Therapy Device. No. K152163. Rockville, MD: FDA. September 29, 2016. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152163.pdf. Accessed July 21, 2023.
US Food and Drug Administration 510(k) Premarket Notification Database. V.A.C.® Therapy Systems. No. K091585. Rockville, MD: FDA. December 29, 2009. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf9/K091585.pdf. Accessed July 21, 2023.
Vuerstaek JD, Vainas T, Wuite J, et al. State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. J Vasc Surg. 2006;44(5):1029-1038.
Webster J, Liu Z, Norman G, et al. Negative pressure wound therapy for surgical wounds healing by primary closure. Cochrane Database Syst Rev. 2019;3:CD009261.
Wynn M, Freeman S. The efficacy of negative pressure wound therapy for diabetic foot ulcers: A systematised review. J Tissue Viability. 2019;28(3):152-160.